The global market for miRNA Tools and Services was estimated to be worth US$ 680 million in 2024 and is forecast to a readjusted size of US$ 1640 million by 2031 with a CAGR of 13.6% during the forecast period 2025-2031.
microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals and some viruses, that functions in RNA silencing and post-transcriptional regulation of gene expression. miRNAs function via base-pairing with complementary sequences within mRNA molecules.
The miRNA tools and services market is driven by the increasing recognition of microRNAs as critical regulators in gene expression, disease progression, and therapeutic targeting. Their roles in cancer, cardiovascular, neurological, and autoimmune diseases have made miRNAs valuable biomarkers for early diagnosis, prognosis, and drug response prediction. Advancements in high-throughput technologies such as next-generation sequencing (NGS), microarrays, and qPCR, along with growing investment in personalized medicine and RNA-based therapeutics, are accelerating the adoption of miRNA analysis tools and services across academic, clinical, and pharmaceutical research sectors.
Despite growing interest, the miRNA tools and services market faces several challenges. The complexity of miRNA biology, including tissue-specific expression and cross-regulation, makes accurate interpretation and validation of results difficult. Additionally, standardization across platforms remains limited, leading to reproducibility issues in research outcomes. High costs of sequencing and bioinformatics analysis, along with a shortage of skilled professionals to handle and interpret large datasets, further hinder widespread adoption, particularly in resource-constrained environments.
This report aims to provide a comprehensive presentation of the global market for miRNA Tools and Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of miRNA Tools and Services by region & country, by Type, and by Application.
The miRNA Tools and Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding miRNA Tools and Services.
Market Segmentation
By Company
- Qiagen
- Thermo Fisher Scientific
- Agilent
- Merck KGaA
- Bio-Rad
- Horizon Discovery
- Illumina
- BioVendor
- Takara Bio
- Promega
- FUJIFILM
- GenoSensor
- Canopy Biosciences
- Phalanx Biotech
- NanoString Technologies
- Zymo Research
- Biocat
- Genecopoeia
Segment by Type
- miRNA Tools
- miRNA Service
Segment by Application
- Research & Academic Institutes
- Pharma & Biotech Companies
- CROs
By Region
- North America
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of miRNA Tools and Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of miRNA Tools and Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of miRNA Tools and Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 miRNA Tools and Services Product Introduction
- 1.2 Global miRNA Tools and Services Market Size Forecast (2020-2031)
- 1.3 miRNA Tools and Services Market Trends & Drivers
- 1.3.1 miRNA Tools and Services Industry Trends
- 1.3.2 miRNA Tools and Services Market Drivers & Opportunity
- 1.3.3 miRNA Tools and Services Market Challenges
- 1.3.4 miRNA Tools and Services Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global miRNA Tools and Services Players Revenue Ranking (2024)
- 2.2 Global miRNA Tools and Services Revenue by Company (2020-2025)
- 2.3 Key Companies miRNA Tools and Services Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies miRNA Tools and Services Product Offered
- 2.5 Key Companies Time to Begin Mass Production of miRNA Tools and Services
- 2.6 miRNA Tools and Services Market Competitive Analysis
- 2.6.1 miRNA Tools and Services Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by miRNA Tools and Services Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in miRNA Tools and Services as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 miRNA Tools
- 3.1.2 miRNA Service
- 3.2 Global miRNA Tools and Services Sales Value by Type
- 3.2.1 Global miRNA Tools and Services Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global miRNA Tools and Services Sales Value, by Type (2020-2031)
- 3.2.3 Global miRNA Tools and Services Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Research & Academic Institutes
- 4.1.2 Pharma & Biotech Companies
- 4.1.3 CROs
- 4.2 Global miRNA Tools and Services Sales Value by Application
- 4.2.1 Global miRNA Tools and Services Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global miRNA Tools and Services Sales Value, by Application (2020-2031)
- 4.2.3 Global miRNA Tools and Services Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global miRNA Tools and Services Sales Value by Region
- 5.1.1 Global miRNA Tools and Services Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global miRNA Tools and Services Sales Value by Region (2020-2025)
- 5.1.3 Global miRNA Tools and Services Sales Value by Region (2026-2031)
- 5.1.4 Global miRNA Tools and Services Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America miRNA Tools and Services Sales Value, 2020-2031
- 5.2.2 North America miRNA Tools and Services Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe miRNA Tools and Services Sales Value, 2020-2031
- 5.3.2 Europe miRNA Tools and Services Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific miRNA Tools and Services Sales Value, 2020-2031
- 5.4.2 Asia Pacific miRNA Tools and Services Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America miRNA Tools and Services Sales Value, 2020-2031
- 5.5.2 South America miRNA Tools and Services Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa miRNA Tools and Services Sales Value, 2020-2031
- 5.6.2 Middle East & Africa miRNA Tools and Services Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions miRNA Tools and Services Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions miRNA Tools and Services Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States miRNA Tools and Services Sales Value, 2020-2031
- 6.3.2 United States miRNA Tools and Services Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States miRNA Tools and Services Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe miRNA Tools and Services Sales Value, 2020-2031
- 6.4.2 Europe miRNA Tools and Services Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe miRNA Tools and Services Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China miRNA Tools and Services Sales Value, 2020-2031
- 6.5.2 China miRNA Tools and Services Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China miRNA Tools and Services Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan miRNA Tools and Services Sales Value, 2020-2031
- 6.6.2 Japan miRNA Tools and Services Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan miRNA Tools and Services Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea miRNA Tools and Services Sales Value, 2020-2031
- 6.7.2 South Korea miRNA Tools and Services Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea miRNA Tools and Services Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia miRNA Tools and Services Sales Value, 2020-2031
- 6.8.2 Southeast Asia miRNA Tools and Services Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia miRNA Tools and Services Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India miRNA Tools and Services Sales Value, 2020-2031
- 6.9.2 India miRNA Tools and Services Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India miRNA Tools and Services Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Qiagen
- 7.1.1 Qiagen Profile
- 7.1.2 Qiagen Main Business
- 7.1.3 Qiagen miRNA Tools and Services Products, Services and Solutions
- 7.1.4 Qiagen miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.1.5 Qiagen Recent Developments
- 7.2 Thermo Fisher Scientific
- 7.2.1 Thermo Fisher Scientific Profile
- 7.2.2 Thermo Fisher Scientific Main Business
- 7.2.3 Thermo Fisher Scientific miRNA Tools and Services Products, Services and Solutions
- 7.2.4 Thermo Fisher Scientific miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.2.5 Thermo Fisher Scientific Recent Developments
- 7.3 Agilent
- 7.3.1 Agilent Profile
- 7.3.2 Agilent Main Business
- 7.3.3 Agilent miRNA Tools and Services Products, Services and Solutions
- 7.3.4 Agilent miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.3.5 Agilent Recent Developments
- 7.4 Merck KGaA
- 7.4.1 Merck KGaA Profile
- 7.4.2 Merck KGaA Main Business
- 7.4.3 Merck KGaA miRNA Tools and Services Products, Services and Solutions
- 7.4.4 Merck KGaA miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.4.5 Merck KGaA Recent Developments
- 7.5 Bio-Rad
- 7.5.1 Bio-Rad Profile
- 7.5.2 Bio-Rad Main Business
- 7.5.3 Bio-Rad miRNA Tools and Services Products, Services and Solutions
- 7.5.4 Bio-Rad miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.5.5 Bio-Rad Recent Developments
- 7.6 Horizon Discovery
- 7.6.1 Horizon Discovery Profile
- 7.6.2 Horizon Discovery Main Business
- 7.6.3 Horizon Discovery miRNA Tools and Services Products, Services and Solutions
- 7.6.4 Horizon Discovery miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.6.5 Horizon Discovery Recent Developments
- 7.7 Illumina
- 7.7.1 Illumina Profile
- 7.7.2 Illumina Main Business
- 7.7.3 Illumina miRNA Tools and Services Products, Services and Solutions
- 7.7.4 Illumina miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.7.5 Illumina Recent Developments
- 7.8 BioVendor
- 7.8.1 BioVendor Profile
- 7.8.2 BioVendor Main Business
- 7.8.3 BioVendor miRNA Tools and Services Products, Services and Solutions
- 7.8.4 BioVendor miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.8.5 BioVendor Recent Developments
- 7.9 Takara Bio
- 7.9.1 Takara Bio Profile
- 7.9.2 Takara Bio Main Business
- 7.9.3 Takara Bio miRNA Tools and Services Products, Services and Solutions
- 7.9.4 Takara Bio miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.9.5 Takara Bio Recent Developments
- 7.10 Promega
- 7.10.1 Promega Profile
- 7.10.2 Promega Main Business
- 7.10.3 Promega miRNA Tools and Services Products, Services and Solutions
- 7.10.4 Promega miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.10.5 Promega Recent Developments
- 7.11 FUJIFILM
- 7.11.1 FUJIFILM Profile
- 7.11.2 FUJIFILM Main Business
- 7.11.3 FUJIFILM miRNA Tools and Services Products, Services and Solutions
- 7.11.4 FUJIFILM miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.11.5 FUJIFILM Recent Developments
- 7.12 GenoSensor
- 7.12.1 GenoSensor Profile
- 7.12.2 GenoSensor Main Business
- 7.12.3 GenoSensor miRNA Tools and Services Products, Services and Solutions
- 7.12.4 GenoSensor miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.12.5 GenoSensor Recent Developments
- 7.13 Canopy Biosciences
- 7.13.1 Canopy Biosciences Profile
- 7.13.2 Canopy Biosciences Main Business
- 7.13.3 Canopy Biosciences miRNA Tools and Services Products, Services and Solutions
- 7.13.4 Canopy Biosciences miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.13.5 Canopy Biosciences Recent Developments
- 7.14 Phalanx Biotech
- 7.14.1 Phalanx Biotech Profile
- 7.14.2 Phalanx Biotech Main Business
- 7.14.3 Phalanx Biotech miRNA Tools and Services Products, Services and Solutions
- 7.14.4 Phalanx Biotech miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.14.5 Phalanx Biotech Recent Developments
- 7.15 NanoString Technologies
- 7.15.1 NanoString Technologies Profile
- 7.15.2 NanoString Technologies Main Business
- 7.15.3 NanoString Technologies miRNA Tools and Services Products, Services and Solutions
- 7.15.4 NanoString Technologies miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.15.5 NanoString Technologies Recent Developments
- 7.16 Zymo Research
- 7.16.1 Zymo Research Profile
- 7.16.2 Zymo Research Main Business
- 7.16.3 Zymo Research miRNA Tools and Services Products, Services and Solutions
- 7.16.4 Zymo Research miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.16.5 Zymo Research Recent Developments
- 7.17 Biocat
- 7.17.1 Biocat Profile
- 7.17.2 Biocat Main Business
- 7.17.3 Biocat miRNA Tools and Services Products, Services and Solutions
- 7.17.4 Biocat miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.17.5 Biocat Recent Developments
- 7.18 Genecopoeia
- 7.18.1 Genecopoeia Profile
- 7.18.2 Genecopoeia Main Business
- 7.18.3 Genecopoeia miRNA Tools and Services Products, Services and Solutions
- 7.18.4 Genecopoeia miRNA Tools and Services Revenue (US$ Million) & (2020-2025)
- 7.18.5 Genecopoeia Recent Developments
8 Industry Chain Analysis
- 8.1 miRNA Tools and Services Industrial Chain
- 8.2 miRNA Tools and Services Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 miRNA Tools and Services Sales Model
- 8.5.2 Sales Channel
- 8.5.3 miRNA Tools and Services Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.2 Author Details
- 10.3 Disclaimer